NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen Further Ameliorates Spinal Muscular Atrophy in Mice
American Journal of Human Genetics - United States
doi 10.1016/j.ajhg.2019.05.008
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2019
Authors
Publisher
Elsevier BV